BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25973294)

  • 1. Podoplanin promotes the invasion of oral squamous cell carcinoma in coordination with MT1-MMP and Rho GTPases.
    Li YY; Zhou CX; Gao Y
    Am J Cancer Res; 2015; 5(2):514-29. PubMed ID: 25973294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moesin regulates the motility of oral cancer cells via MT1-MMP and E-cadherin/p120-catenin adhesion complex.
    Li YY; Zhou CX; Gao Y
    Oral Oncol; 2015 Oct; 51(10):935-43. PubMed ID: 26194050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdc42 and RhoA have opposing roles in regulating membrane type 1-matrix metalloproteinase localization and matrix metalloproteinase-2 activation.
    Ispanovic E; Serio D; Haas TL
    Am J Physiol Cell Physiol; 2008 Sep; 295(3):C600-10. PubMed ID: 18562481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail regulates the motility of oral cancer cells via RhoA/Cdc42/p-ERM pathway.
    Li YY; Zhou CX; Gao Y
    Biochem Biophys Res Commun; 2014 Sep; 452(3):490-6. PubMed ID: 25172658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signaling.
    Fisher KE; Pop A; Koh W; Anthis NJ; Saunders WB; Davis GE
    Mol Cancer; 2006 Dec; 5():69. PubMed ID: 17156449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression.
    Mitre GP; Balbinot KM; Ribeiro ALR; da Silva Kataoka MS; de Melo Alves Júnior S; de Jesus Viana Pinheiro J
    Diagn Pathol; 2021 Apr; 16(1):33. PubMed ID: 33879222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM; Neurath KM; Vumbaca F; Claffey KP
    Oncogene; 2006 Apr; 25(16):2379-92. PubMed ID: 16369494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel protein associated with membrane-type 1 matrix metalloproteinase binds p27(kip1) and regulates RhoA activation, actin remodeling, and matrigel invasion.
    Hoshino D; Tomari T; Nagano M; Koshikawa N; Seiki M
    J Biol Chem; 2009 Oct; 284(40):27315-26. PubMed ID: 19654316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.
    Al Haddad M; El-Rif R; Hanna S; Jaafar L; Dennaoui R; Abdellatef S; Miskolci V; Cox D; Hodgson L; El-Sibai M
    Cell Commun Signal; 2020 Sep; 18(1):144. PubMed ID: 32900380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDCP1 regulates the function of MT1-MMP and invadopodia-mediated invasion of cancer cells.
    Miyazawa Y; Uekita T; Ito Y; Seiki M; Yamaguchi H; Sakai R
    Mol Cancer Res; 2013 Jun; 11(6):628-37. PubMed ID: 23439492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
    Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
    J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma.
    Myoung H; Kim MJ; Hong SD; Lee JI; Lim CY; Hong SP
    Cancer Lett; 2002 Nov; 185(2):201-9. PubMed ID: 12169394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
    Li YY; Zhou CX; Gao Y
    Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt5b promotes the cell motility essential for metastasis of oral squamous cell carcinoma through active Cdc42 and RhoA.
    Takeshita A; Iwai S; Morita Y; Niki-Yonekawa A; Hamada M; Yura Y
    Int J Oncol; 2014 Jan; 44(1):59-68. PubMed ID: 24220306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices.
    Fisher KE; Sacharidou A; Stratman AN; Mayo AM; Fisher SB; Mahan RD; Davis MJ; Davis GE
    J Cell Sci; 2009 Dec; 122(Pt 24):4558-69. PubMed ID: 19934222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdc42-interacting protein 4 is a Src substrate that regulates invadopodia and invasiveness of breast tumors by promoting MT1-MMP endocytosis.
    Hu J; Mukhopadhyay A; Truesdell P; Chander H; Mukhopadhyay UK; Mak AS; Craig AW
    J Cell Sci; 2011 May; 124(Pt 10):1739-51. PubMed ID: 21525036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.
    Wicki A; Lehembre F; Wick N; Hantusch B; Kerjaschki D; Christofori G
    Cancer Cell; 2006 Apr; 9(4):261-72. PubMed ID: 16616332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.
    Bartolomé RA; Gálvez BG; Longo N; Baleux F; Van Muijen GN; Sánchez-Mateos P; Arroyo AG; Teixidó J
    Cancer Res; 2004 Apr; 64(7):2534-43. PubMed ID: 15059909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1 facilitates MT1-MMP-mediated proMMP-9 activation and invasion in oral squamous cell carcinoma cells.
    Yamahana H; Terashima M; Takatsuka R; Asada C; Suzuki T; Uto Y; Takino T
    Biochem Biophys Rep; 2021 Sep; 27():101072. PubMed ID: 34381878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells.
    Saby C; Collin G; Sinane M; Buache E; Van Gulick L; Saltel F; Maquoi E; Morjani H
    Front Pharmacol; 2019; 10():462. PubMed ID: 31130862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.